dos and don'ts semaglutide We preach this everyday to our weight loss clients, but just a reminder for those of you taking or Tirzepatide…nutrition is KEY! If you are interested in more education, join our Semaglutide vs. Tirzepatide for Weight

Important Disclaimer All information above is for educational and research purposes only

[DOI] [PubMed] [Google Scholar] 970.Heller SR, Pratley RE, Sinclair A, et al

Instead, it comes down to always maintaining an index of suspicion in any patient that has not been diagnosed with an IUP, using your clinical expertise on the risk factors and clinical features of ectopic pregnancy: Ectopic risk factors history Previous Ectopic Miscarriage/abortion Tubal surgery or other pathology (eg

placebo over 52 weeks Efficacy observed both as monotherapy or combined with antifibrotics Well-tolerated, reduced death risk, though did not show statistically significant survival benefit Why it matters: Anti-inflammatory mechanism differentiates JASCAYD from existing antifibrotics (nintedanib, pirfenidone) Reinforces Boehringers leadership in respiratory innovation and re-energizes IPF R&D after years of limited breakthroughs Follow our page for more such updates: News Source: #FDAApproval #IPF #PulmonaryFibrosis #Respiratory #RespiratoryMedicine #DrugDevelopment #BoehringerIngelheim #Ofev #Esbriet #PharmaInnovation To view or add a comment, sign in PYC today announced that we have initiated a global repeat dose study of PYC-001 in patients with ADOA (known as the MYRTLE study) and that the first subject in this clinical trial has now received their initial dose of PYC-001 - The objective of the MYRTLE study is to evaluate the safety/tolerability and efficacy profile of repeat dosing of PYC-001 in the ADOA population with a view to establishing clinical proof of concept for the drug candidate prior to initiation of a registrational study - Data from the Myrtle study across both safety/tolerability and efficacy endpoints is expected to be available in H2 2026 Read the full announcement here: To view or add a comment, sign in First new therapy for IPF in over 10 years

Because the uterus is not the only thing that bleeds Part 2: Post Menopausal Bleeding: When the Uterus is the Culprit, covers postmenopausal bleeding that originates from the uterus

In Mounjaro, tirzepatide acts as a diabetes medication, whereas in Zepbound, it is a weight loss drug